Skip to main content
Premium Trial:

Request an Annual Quote

BGI Acquires 27 SOLiD 4 Sequencers

Premium

This story was originally published Oct. 29.

Life Technologies said last week that China's BGI has acquired 27 SOLiD 4 systems, which will allow BGI to sequence 50 whole human genomes per month.

Li Jingxiang, vice president of genomics operations for BGI, said in a statement that the SOLiDs will enable the institute to "secure sequence data for a complete whole human genome on 30x coverage that includes 100 gigabases of mapped data at an accuracy of 99.9 percent."

The new SOLiDs will join a fleet of Illumina machines at BGI. In January, the institute ordered 128 HiSeq 2000 sequencers, which have been installed over the course of the year (IS 1/12/2010).

Paul Tu, president of BGI Americas, told In Sequence in September that by the end of the year, BGI's Hong Kong location will have at least 100 Illumina HiSeq 2000 machines and 20 SOLiD instruments, while BGI's Shenzhen facility will have 37 HiSeq 2000 instruments and between 5 and 10 SOLiD instruments.

Tu said at the time that the number of SOLiDs might grow, "depending on the customer demand in human resequencing." (IS 9/21/2010)

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more